KPC-producing Enterobacter aerogenes infection

Brazilian Journal of Infectious Diseases

Volumn 19, Issue 3, 2015, Pages 324-327

  Tuon, Felipe F ^a   Scharf, Camila ^a   Rocha, Jaime L ^b   Cieslinsk, Juliette ^a   Becker, Guilherme Nardi ^a   Arend, Lavinia N ^c  

^a HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^b Division of Microbiology   (Brazil)

^c Laboratório Central do Estado LACEN PR   (Brazil)

Author keywords

Carbapenemase; Enterobacter; Infection control; KPC

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEMASE; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE KPC-2;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MONOTHERAPY; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; DRUG EFFECTS; ENZYMOLOGY; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREGNANCY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84930089014     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2015.01.003     Document Type: Article

References (11)

1. Tuon F.F., Bianchet L.C., Penteado-Filho S.R. Epidemiology of extended spectrum beta-lactamase producing Enterobacter bacteremia in a Brazilian hospital. Rev Soc Bras Med Trop 2010, 43:452-454.
2. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9:228-236.
3. Bradford P.A., Bratu S., Urban C., et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 2004, 39:55-60.
4. Satlin M.J., Jenkins S.G., Chen L., et al. Septic shock caused by Klebsiella pneumoniae carbapenemase-producing Enterobacter gergoviae in a neutropenic patient with leukemia. J Clin Microbiol 2013, 51:2794-2796.
5. Clinical Laboratory Standard Institute (CLSI) Performance standard for antimicrobial susceptibility testing; twenty-third informational supplement 2013.
6. Tuon F.F., Rocha J.L., Toledo P., et al. Risk factors for KPC-producing Klebsiella pneumoniae bacteremia. Braz J Infect Dis 2012, 16:416-419.
7. Pankey G.A. Tigecycline. J Antimicrob Chemother 2005, 56:470-480.
8. Trevino M., Navarro D., Barbeito G., et al. Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight. Microb Drug Resist 2011, 17:433-442.
9. ANVISA Critérios Nacionais de Infecçes relacionadas à Assistência à Saúde 2009, Ministerio da Saude.
10. Tuon F.F., Rocha J.L., Formighieri M.S., et al. Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil. J Infect 2013, 67:247-249.
11. Gasink L.B., Edelstein P.H., Lautenbach E., et al. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009, 30:1180-1185.